2430 N. HALSTED ST., CHICAGO, IL
Director Resignation and Appointment; Board Size Increased to Six
Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Director Appointment - Yoontae Han Joins Exicure Board
.3Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
Financial Results, Press Release
Executive Management Change - Jung Soo Kim Appointed CEO
Board Resignations and Appointments at Exicure, Inc. on February 6, 2026
Exicure, Inc. Achieves Milestone 1; $1 Million Payment to GPCR Therapeutics
Notice of Late Filing for Quarterly Report
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload